A retrospective study evaluating the evolution of UST levels in an intensified maintenance regimen, their capacity to discriminate response according to inflammatory parameters and to indicate the need of further intensification
Latest Information Update: 06 Jul 2021
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021